Klaus Schmierer

40PUBLICATIONS
78CO-AUTHORS
Software quality, processes and metricsReinforcement learningCancer therapy (excl. chemotherapy and radiation therapy)People with disabilityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 28, 2026
Diagnosing multiple sclerosis: implementation and unintended effects of the 2024 McDonald criteria.

|Aug 04, 2026
Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

|Jul 06, 2026
Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?

|May 01, 2026
Understanding the Unmet Needs of People with MS at Diagnosis and Throughout Their Care Journey: Insights from a Survey-Based Study.

|Aug 04, 2025
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study.

Klaus Schmierer, Heinz Wiendl, Frederik Barkhof

|Jun 27, 2025
Mechanistic biology linking traumatic brain injury to multiple sclerosis susceptibility.

David Baker, Lars Alfredsson, Anna Karin Hedström

Pageof 7

Frequent Collaborators

7 joint publications

David Baker

5 joint publications

Kimberley Allen-Philbey

4 joint publications

Emma C Tallantyre

3 joint publications

Gavin Giovannoni